Cas no 885518-90-1 (4-Methyl-1H-indazole-3-carboxylic acid)

4-Methyl-1H-indazole-3-carboxylic acid is a heterocyclic carboxylic acid derivative featuring an indazole core structure with a methyl substituent at the 4-position and a carboxylic acid group at the 3-position. This compound serves as a versatile intermediate in organic synthesis and pharmaceutical research, particularly in the development of biologically active molecules. Its rigid indazole scaffold and functional groups make it valuable for constructing complex frameworks, such as kinase inhibitors or other therapeutic agents. The carboxylic acid moiety allows for further derivatization via amidation or esterification, enhancing its utility in medicinal chemistry. High purity grades are available to meet rigorous research and industrial requirements.
4-Methyl-1H-indazole-3-carboxylic acid structure
885518-90-1 structure
Product Name:4-Methyl-1H-indazole-3-carboxylic acid
CAS No:885518-90-1
MF:C9H8N2O2
MW:176.172021865845
MDL:MFCD07781461
CID:890412
Update Time:2025-05-20

4-Methyl-1H-indazole-3-carboxylic acid Chemical and Physical Properties

Names and Identifiers

    • 4-Methyl-1H-indazole-3-carboxylic acid
    • 1H-INDAZOLE-3-CARBOXYLIC ACID,4-METHYL-
    • 4-Methyl-3-(1H)indazole carboxylic acid
    • 4-Methyl-3-indazole carboxylic acid
    • 4-Methyl-1H-indazole-3-carboxylic acid (ACI)
    • MDL: MFCD07781461
    • Inchi: 1S/C9H8N2O2/c1-5-3-2-4-6-7(5)8(9(12)13)11-10-6/h2-4H,1H3,(H,10,11)(H,12,13)
    • InChI Key: PNRZINGBFITCFA-UHFFFAOYSA-N
    • SMILES: O=C(C1C2C(=CC=CC=2C)NN=1)O

Computed Properties

  • Exact Mass: 176.05900
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 13
  • Rotatable Bond Count: 1

Experimental Properties

  • PSA: 65.98000
  • LogP: 1.56950

4-Methyl-1H-indazole-3-carboxylic acid Customs Data

  • HS CODE:2933990090
  • Customs Data:

    China Customs Code:

    2933990090

    Overview:

    2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-Methyl-1H-indazole-3-carboxylic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0406-1g
4-Methyl-1H-indazole-3-carboxylic acid
885518-90-1 97%
1g
4223.25CNY 2021-05-07
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0406-5g
4-Methyl-1H-indazole-3-carboxylic acid
885518-90-1 97%
5g
14840.74CNY 2021-05-07
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0406-500mg
4-Methyl-1H-indazole-3-carboxylic acid
885518-90-1 97%
500mg
2535.65CNY 2021-05-07
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0406-250mg
4-Methyl-1H-indazole-3-carboxylic acid
885518-90-1 97%
250mg
1687.6CNY 2021-05-07
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0406-100mg
4-Methyl-1H-indazole-3-carboxylic acid
885518-90-1 97%
100mg
1263.58CNY 2021-05-07
Chemenu
CM132910-1g
4-methyl-1H-indazole-3-carboxylic acid
885518-90-1 95%
1g
$310 2021-08-05
TRC
M643305-10mg
4-methyl-1H-indazole-3-carboxylic acid
885518-90-1
10mg
$ 50.00 2022-06-03
TRC
M643305-50mg
4-methyl-1H-indazole-3-carboxylic acid
885518-90-1
50mg
$ 135.00 2022-06-03
TRC
M643305-100mg
4-methyl-1H-indazole-3-carboxylic acid
885518-90-1
100mg
$ 210.00 2022-06-03
abcr
AB536877-1 g
4-Methyl-1H-indazole-3-carboxylic acid; .
885518-90-1
1g
€462.00 2023-07-11

Additional information on 4-Methyl-1H-indazole-3-carboxylic acid

4-Methyl-1H-indazole-3-carboxylic Acid (CAS No. 885518-90-1): An Overview of Its Structure, Synthesis, and Biological Applications

4-Methyl-1H-indazole-3-carboxylic acid (CAS No. 885518-90-1) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of indazoles, which are known for their diverse biological activities, including anti-inflammatory, anti-cancer, and neuroprotective properties. The unique structure of 4-methyl-1H-indazole-3-carboxylic acid makes it a valuable building block for the synthesis of more complex molecules with potential therapeutic applications.

The chemical structure of 4-methyl-1H-indazole-3-carboxylic acid consists of an indazole ring system with a methyl group at the 4-position and a carboxylic acid group at the 3-position. The indazole ring is a fused heterocyclic system comprising a pyrazole and a benzene ring. The presence of the carboxylic acid group imparts acidic properties to the molecule, making it suitable for various chemical reactions and biological interactions.

The synthesis of 4-methyl-1H-indazole-3-carboxylic acid has been extensively studied, and several methods have been reported in the literature. One common approach involves the reaction of 4-methylindazole with carbon dioxide in the presence of a suitable catalyst. Another method involves the cyclization of an appropriate precursor, such as an amide or nitrile, followed by oxidation to form the carboxylic acid group. These synthetic routes have been optimized to achieve high yields and purity, making 4-methyl-1H-indazole-3-carboxylic acid readily available for further research and development.

In recent years, 4-methyl-1H-indazole-3-carboxylic acid has been explored for its potential therapeutic applications. One area of significant interest is its use as a scaffold for the development of inhibitors targeting various enzymes and receptors. For example, derivatives of 4-methyl-1H-indazole-3-carboxylic acid have shown promising activity as inhibitors of histone deacetylases (HDACs), which are implicated in various diseases, including cancer and neurodegenerative disorders. The ability to modulate HDAC activity through these derivatives could lead to new treatments for these conditions.

Beyond HDAC inhibition, 4-methyl-1H-indazole-3-carboxylic acid has also been investigated for its anti-inflammatory properties. Inflammation is a key factor in many chronic diseases, and compounds that can effectively reduce inflammation without causing significant side effects are highly sought after. Studies have shown that certain derivatives of 4-methyl-1H-indazole-3-carboxylic acid exhibit potent anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines and mediators.

The neuroprotective potential of 4-methyl-1H-indazole-3-carboxylic acid has also been explored. Neurodegenerative diseases such as Alzheimer's and Parkinson's are characterized by the progressive loss of neurons, and there is a critical need for effective treatments to halt or reverse this process. Research has indicated that derivatives of 4-methyl-1H-indazole-3-carboxylic acid can protect neurons from oxidative stress and promote neuronal survival, making them promising candidates for further investigation in this area.

In addition to its therapeutic applications, 4-methyl-1H-indazole-3-carboxylic acid has been used as a tool compound in biochemical studies to understand the mechanisms underlying various biological processes. For instance, it has been employed to investigate the role of specific enzymes in cellular signaling pathways and to identify novel targets for drug discovery.

The safety profile of 4-methyl-1H-indazole-3-carboxylic acid is an important consideration for its potential use in pharmaceutical applications. Preclinical studies have generally shown that this compound is well-tolerated at therapeutic doses, with minimal toxicity observed in animal models. However, further research is needed to fully evaluate its safety in humans.

In conclusion, 4-methyl-1H-indazole-3-carboxylic acid (CAS No. 885518-90-1) is a multifaceted compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for the development of new therapeutic agents targeting various diseases. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical uses, highlighting its importance in modern drug discovery efforts.

Recommended suppliers
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
Zouping Mingyuan Import and Export Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zouping Mingyuan Import and Export Trading Co., Ltd
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD